-
Mashup Score: 1
Findings from the PRODIGE 59-FFCD 1707-DURIGAST study
Source: www.esmo.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Immunotherapy in Gastric Cancer - 1 month(s) ago
Although its value was rapidly recognized in the treatment of other cancers, immunotherapy with immune checkpoint inhibitors (ICIs) has achieved slower success in the treatment of gastric and gastroesophageal adenocarcinoma. After mixed results in second-line, third-line therapy, and beyond when…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
An honor to have been invited to write the following editorial accompanying this article. Thanks to @JAMAOnc https://t.co/2lFcqkt3ND https://t.co/NBUZBYwlKL
-
-
Mashup Score: 14Choosing the Right Test for the Right Patient at the Right Time: Establishing Guidelines for Molecular Panels in Sarcomas - 6 month(s) ago
Commercially available platforms in the management of sarcomas are expanding in terms of the technology used, breadth of coverage, depth of coverage, specimen assayed, and gene lists tested. Thus, it is a critical time to ask the question: Is it time to provide guidelines on how to select a comprehensive panel based on the tumor type?
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
I was happy to write with my colleague @candace_haddox this opinion piece about the need of a consensus for the use of molecular panels in sarcomas. Thank you @asco and #ascodailynews ! https://t.co/ziFnabOIzw
-
-
Mashup Score: 1ASCO Education : Cancer Topics - Oncology Practice in Low-Resource Settings sur Apple Podcasts - 7 month(s) ago
Afficher ASCO Education, ép Cancer Topics – Oncology Practice in Low-Resource Settings – 10 oct. 2023
Source: podcasts.apple.comCategories: Hematologists1, Latest HeadlinesTweet-
Having studied in Haiti, an LMIC country, I really enjoyed being the host in this podcast where we talk about practice in low-resource places, whether in Jordan or in the US. https://t.co/7RiLdaHfHU
-
-
Mashup Score: 1Emerging predictive biomarkers in the management of bone and soft tissue sarcomas - PubMed - 1 year(s) ago
While predictive biomarkers are not routinely used in sarcoma clinical practice currently, emerging biomarkers are being developed alongside clinical advancements. Novel therapies and predictive biomarkers will be essential for individualizing future approaches to sarcoma management and improving pa …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/AUDwrArbGg Happy to highlight this excellent review article by my colleague @candace_haddox in collaboration with @richardriedelmd . Some of these biomarkers will make their way into clinical practice, I am sure.
-
-
Mashup Score: 0
Current ERBB2 status may be more effective than archival status at predicting clinical benefit from margetuximab plus pembrolizumab therapy. ctDNA testing for ERBB2 status prior to treatment will spare patients from repeat tissue biopsies, which may be reserved for reflex testing when ctDNA is not d …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/NyjU79Jy3J This paper looks at the value of ctDNA in HER2+ GEA, but its conclusion is probably valid in other malignancies as well: a sensitive ctDNA test may spare patients a repeat biopsy before administration of targeted therapy.
-
-
Mashup Score: 0
Undifferentiated small round cell sarcomas (URCSs) represent a diagnostic challenge and their optimal treatment is unknown. We aimed to define the clinical characteristics, treatment and outcome of URCS patients.
Source: European Journal of CancerCategories: Hem/Oncs, Latest HeadlinesTweet-
A large and informative retrospective study about the outcomes of these poorly understood undifferentiated round cell sarcomas (aka non-Ewing). This is now the time for prospective clinical trials. https://t.co/aqbteP71Ab
-
-
Mashup Score: 0
The human upper respiratory tract is the first site of contact for inhaled respiratory viruses and elaborates an array of innate immune responses. Seasonal variation in respiratory viral infections and the importance of ambient temperature in modulating immune responses to infections have been well recognized; however, the underlying biological mechanisms remain understudied.
Categories: Hem/Oncs, Latest HeadlinesTweet-
A fantastic and scientific explanation of how we get colds and other URI. Prendre froid s’explique scientifiquement! https://t.co/RVOHAgvdGN
-
-
Mashup Score: 0
This quasi-experimental study determines whether peer relationships between primary care physicians and specialists formed during training motivate improved specialist care for patients.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
I believe the results of this study: how friendship, or at least, good relationships between physicians can improve patient care. https://t.co/MIa6BV3L5o
-
-
Mashup Score: 6Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline - 1 year(s) ago
PURPOSE To develop recommendations involving targeted therapies for patients with advanced gastroesophageal cancer. METHODS The American Society of Clinical Oncology convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. RESULTS Eighteen randomized controlled trials met the inclusion criteria for the systematic review….
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Proud to have contributed to a timely guideline on an important topic. Thanks to @ASCO for the invitation to be a co-author! https://t.co/T4GrhKxQA4
-
My editorial mas mentioned by @myESMO Oncology News! Thanks again to @JAMAOnc for the invitation. https://t.co/g76AAaXVvp